Belvedere Trading LLC Anavex Life Sciences Corp. Call Options Transaction History

Belvedere Trading LLC

  • $80.4 Billion
  • Q2 2024

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 09, 2024
SELL
$4.55 - $6.75 $10,465 - $15,525
-2,300 Reduced 8.75%
24,000 $122,000
Q4 2023

Feb 13, 2024
SELL
$5.04 - $9.95 $9,072 - $17,910
-1,800 Reduced 6.41%
26,300 $244,000
Q3 2023

Oct 27, 2023
BUY
$6.55 - $9.37 $9,170 - $13,117
1,400 Added 5.24%
28,100 $184,000
Q2 2023

Aug 08, 2023
BUY
$7.66 - $9.5 $204,522 - $253,650
26,700 New
26,700 $217,000
Q4 2022

Feb 14, 2023
BUY
$7.65 - $14.43 $154,530 - $291,486
20,200 New
20,200 $187,000

Others Institutions Holding AVXL

# of Institutions
152
Shares Held
26.5M
Call Options Held
674K
Put Options Held
811K
View Full List

About ANAVEX LIFE SCIENCES CORP.

AVXL Quotes by TradingView
  • Ticker AVXL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,942,800
  • Market Cap $436M
  • Description
  • Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...
More about AVXL
Track This Portfolio

Track Belvedere Trading LLC Portfolio

Follow Belvedere Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belvedere Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belvedere Trading LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email